Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

6 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 4
6(85.7%)
Phase 2
1(14.3%)
7Total
Phase 4(6)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07542652Recruiting

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis

Role: lead

NCT07546097Phase 4Recruiting

Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）

Role: lead

NCT06617182Phase 2Recruiting

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

Role: lead

NCT06610760Phase 4Recruiting

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

Role: lead

NCT07139366Phase 4Recruiting

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Role: lead

NCT07068607Phase 4Recruiting

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial

Role: lead

NCT06168084Phase 4Completed

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Role: lead

NCT06610266Phase 4Recruiting

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Role: lead

All 8 trials loaded